Tirzepatide
TZP
Eli Lilly · Phase 2/3 · Recruiting · Enrollment 105
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Tirzepatide group | n/r | n/r | n/r | n/r | n/r |
| Control group | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.